Moreover, two recent studies reported the development of novel dual HDAC and HSP90 inhibitors, where a single small molecule inhibited both HDAC and HSP90 that were tested on age-related macular degeneration [62] and leukemia [63]. This evidence concerns the gene HDAC9 and age-related macular degeneration.